Glioblastomas of the mesenchymal methylation subtype demonstrated significantly higher median and p90 APTw signal intensity compared with RTK1 and RTK2 subtypes, independent of MGMT status and Ki-67 index. The gene discussed is MGMT; the disease is glioblastoma.